Effect of NG‐monomethyl‐L‐arginine on kinin‐induced vasodilation in the human forearm.

Abstract
1. We compared effects of NG‐monomethyl‐L‐arginine (L‐NMMA), an NO synthase inhibitor, on vasodilator responses to intra‐arterial infusion of bradykinin and substance P in the human forearm. 2. Bradykinin (100 pmol min‐1) increased forearm blood flow when infused into the brachial artery of eight healthy male volunteers, from 2.8 +/‐ 0.2 (mean +/‐ s.e. mean) to 9.3 +/‐ 1.0 ml min‐1 per 100 ml forearm volume. 3. Co‐ infusion of L‐NMMA (2 mumol min‐1 and 4 mumol min‐1) with bradykinin (100 pmol min‐1) for 6 min produced respectively a 9 +/‐ 14% and 42 +/‐ 14% inhibition (compared with L‐NMMA vehicle) in the response to bradykinin. 4. Substance P (1 pmol min‐1) when infused into the brachial artery of a further eight male subjects increased forearm blood flow from 3.4 +/‐ 0.2 to 6.3 +/‐ 0.7 ml min‐1 100 ml‐1. 5. Co‐ infusion of L‐NMMA (2 mumol min‐1 and 4 mumol min‐1) with substance P (1 pmol min‐1) for 6 min produced respectively a 27 +/‐ 8% and 70 +/‐ 13% inhibition (compared with L‐NMMA vehicle) in the response to substance P. 6. These results demonstrate that vasodilator responses to both bradykinin and substance P are mediated in part via the L‐ arginine/NO pathway. Bradykinin and substance P may be useful agonists with which to study endothelial function in this vascular bed.